News Kilpatrick Townsend has adviced Pixelgen Technologies AB in connection with an investment for continuous research and development

Kilpatrick Townsend has represented Pixelgen Technologies AB in connection with an investment from Navigare Ventures as lead investor and other investors. Pixelgen Technologies AB develop technologies, products, software, and services for the analyses of biological samples using nucleic acid encoded pixels capable of generating virtual images of a sample. Pixelgen Technologies has raised approximately 6 MUSD and the investment will be used for continuous research and development of Pixelgen Technologies product- and services offer.

Kilpatrick Townsends team comprised of Tobias Öd and Cecilia Qvist.

Kilpatrick Townsends corporate team regularly represents investors, founders, buyers and sellers and we have great experience of venture capital transactions. We have been entrusted to work with some of Sweden’s most interesting growth companies and their founders.